Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 13, 2026 17:25 ET | Source: Jet.AI Inc.

Jet.AI Closes Transaction with flyExclusive, Advancing Transition to a Pure-Play AI Infrastructure

LAS VEGAS, July 13, 2026 (GLOBE NEWSWIRE) -- Jet.AI Inc. (NASDAQ: JTAI) (“Jet.AI” or the “Company”), an emerging provider of high-performance GPU infrastructure and AI cloud services, announced the...
July 13, 2026 17:01 ET | Source: Tavia Acquisition Corp.

Tavia Acquisition Corp. and Vita Inclinata Technologies Sign Letter of Intent to go public on NASDAQ

London, United Kingdom, July 13, 2026 (GLOBE NEWSWIRE) -- Tavia Acquisition Corp. (Nasdaq: TAVI) ("Tavia") and Vita Inclinata Technologies, Inc. ("Vita") today announced they have signed a Letter...
July 13, 2026 17:00 ET | Source: Univest Securities, LLC

Univest Securities, LLC Announces Closing of $4 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)

New York, July 13, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York,...
July 13, 2026 17:00 ET | Source: Beneficient

Beneficient Closes $7.44 Million GP Primary Capital Transaction

Beneficient closed on the financing of a $7.44 million primary capital commitment in Quartus AI Fund II.
July 13, 2026 16:32 ET | Source: Aecon Group Inc.

Aecon consortium selected as preferred proponent for the Roberts Bank Terminal 2 – Landmass and Wharf progressive design-build project in British Columbia

TORONTO, July 13, 2026 (GLOBE NEWSWIRE) -- Aecon Group Inc. (TSX: ARE) (“Aecon”) announced today that TerraMarine, an Aecon consortium with FlatironDragados Canada Inc., Van Oord, and Carlson...
July 13, 2026 16:15 ET | Source: MBX Biosciences, Inc.

MBX Biosciences Announces Executive Leadership Transition to Support the Company’s Next Phase of Growth

CARMEL, Ind. and BURLINGTON, Mass., July 13, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and...
July 13, 2026 16:15 ET | Source: DHT Holdings, Inc.

DHT Holdings, Inc. Business Update

HAMILTON, BERMUDA, July 13, 2026 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today provides the following business update: For the second quarter of 2026, the Company estimates time...
July 13, 2026 16:12 ET | Source: Orchid Island Capital, Inc.

Orchid Island Capital Announces Estimated Second Quarter 2026 Results and June 30, 2026 RMBS Portfolio Characteristics

Estimated Book Value Per Share as of June 30, 2026 of $7.22Estimated GAAP net income of $0.44 per share for the quarter ended June 30, 2026 including an estimated $0.18 per share of net realized and...
July 13, 2026 16:05 ET | Source: Tarsus Pharmaceuticals, Inc

Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth

IRVINE, Calif., July 13, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) today announced that Aziz Mottiwala, Chief Commercial Officer, is departing the Company to pursue a new...
July 13, 2026 16:05 ET | Source: Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals Strengthens Executive Leadership Team to Support Next Phase of Growth

VANCOUVER, British Columbia, July 13, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company...